title: Sequential analysis of the pathogenesis of plutonium-induced pulmonary neoplasms in the rat: morphology, morphometry, and cytokinetics.
abstract: Light microscopy, morphometry, and cytokinetic techniques were used to examine the dynamics of plutonium-induced pulmonary proliferative lesions and neoplasms in rats at several intervals to 450 days after inhalation exposure to aerosols of 239PuO2. Maximal increases in alveolar and bronchiolar epithelial cell labeling were seen at 30 days; decreasing subsequently, the levels remained elevated above control indices. Focal proliferative epithelial lesions developed in the lung by 180 days and before the onset of pulmonary neoplasms. Pulmonary neoplasms, predominantly adenocarcinomas and squamous cell carcinomas, were initially observed at 308 days. The proliferative lesions progressed through a succession of morphological changes leading to the development of neoplasms. The volume density (fraction) and epithelial surface area of foci of alveolar epithelial hyperplasia increased progressively between 180 and 450 days after exposure, in contrast to the other proliferative lesions. We conclude that plutonium-induced pulmonary neoplasms develop through a succession of focal proliferative lesions that represent developmental preneoplastic lesions. Progressive increases in volume and epithelial surface area of the alveolar epithelial hyperplasias suggest that they may be more at risk for neoplastic transformation than the other histological types of proliferative foci.
authors: Inhalation Toxicology Research Institute, Albuquerque, New Mexico 87185.
authors: R A
authors: RA
authors: Herbert
authors: N A
authors: NA
authors: Gillett
authors: A H
authors: AH
authors: Rebar
authors: D L
authors: DL
authors: Lundgren
authors: M D
authors: MD
authors: Hoover
authors: I Y
authors: IY
authors: Chang
authors: W W
authors: WW
authors: Carlton
authors: F F
authors: FF
authors: Hahn
mesh_terms: D000230:Adenocarcinoma / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D000280:Administration, Inhalation; D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D002453:Cell Cycle / Q000528:radiation effects; D005260:Female; D008175:Lung Neoplasms / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D009381:Neoplasms, Radiation-Induced / Q000473:pathology* / Q000503:physiopathology; D011005:Plutonium / Q000008:administration & dosage / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: C026885:plutonium dioxide; D011005:Plutonium